References

1. Depression. Substance Abuse and Mental Health Services Administration (SAMHSA). Updated April 24, 2023. Accessed June 11, 2025. https://www.samhsa.gov/mental-health/what-is-mental-health/conditions/depression
2. Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M. The STAR*D study: treating depression in the real world. Cleve Clin J Med. 2008;75(1):57–66.
3. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health (HHS Publication No. PEP24-07-021, NSDUH Series H.59). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2024. Accessed June 11, 2025. https://www.samhsa.gov/data/report/2023-nsduh-annual-national-report
4. Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336–346. doi:10.1001/jamapsychiatry.2017.4602
5. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer‑term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–1917. doi:10.1176/ajp.2006.163.11.1905
6. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (third edition); 2010.
7. CAPLYTA Prescribing Information.
8. Kao CH. Neurotransmitters and their influence on mental health disorders. Neurosci Psych Open Access. 2024;7(6):284–286. doi:10.47532/npoa.2024.7(6).284‑286
9. Montano CB, Jackson WC, Vanacore D, Weisler R. Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression. Postgrad Med. 2023;135(5):449–465. doi:10.1080/00325481.2023.2189868
10. Shankar GS. Serotonin and sexual dysfunction. J Autacoids Horm. 2015;5(1):e129. doi:10.4172/2161‑0479.1000e129
11. Data on File (REF-02960).